MHRA announces Good Clinical Practice (GCP) Discussion Forum

The U.K. Medicines and Healthcare products Regulatory Agency MHRA has created a GCP Discussion Forum to help all those involved in the conduct of clinical trials implement quality procedures that can ensure compliance with clinical trials legislation and GCP requirements.

The platform also provides the ideal opportunity for an extended communication between researchers and allows users to put forward their comments and get 'real-life' examples.